Current microfluidics-enabled point-of-care diagnostic systems are typically designed specifically for one assay type, e.g. a molecular diagnostic assay for a single disease of a class of diseases. This approach often leads to high development cost and a significant training requirement for users of different instruments. We have developed an open platform diagnostic system which allows to run molecular, immunological and clinical assays on a single instrument platform with a standardized microfluidic cartridge architecture in an automated sample-in answer-out fashion. As examples, a molecular diagnostic assay for tuberculosis, an immunoassay for HIV p24 and a clinical chemistry assay for ALT liver function have been developed and results of their pre-clinical validation are presented.

© 2016 COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.

Holger Becker, Richard Klemm, William Dietze, Wallace White, Nadine Hlawatsch, Susanne Freyberg, Christian Moche, Peter Dailey, and Claudia Gärtner, "Modular microfluidic cartridge-based universal diagnostic system for global health applications," Proc. SPIE 9705, Microfluidics, BioMEMS, and Medical Microsystems XIV, 970514 (Presented at SPIE BiOS: February 15, 2016; Published: 18 March 2016); https://doi.org/10.1117/12.2217892.